Once you stop, your body resumes its natural pigment cycle
Individual substances cannot fully support this cycle
Preclinical animal studies further validate its neuroprotective potential: phillyrin A improves learning and memory in senescence-accelerated mice, activates the Nrf2 signaling pathway in APP/PS1 mice, upregulates antioxidant proteins (NQO1, GPX4), and normalizes cerebral iron content through modulation of TFRC, DMT1, FTH, and FTL gene expression (234)
10.1161/01.ATV.0000189306.99112.4c 238 PaikW
A pilot human safety study with n=2 is far too small to support broad safety claims, and regulatory sources flag concerns about unapproved use, dose uncertainty, impurities, and lack of established therapeutic dosing [10][1516]